Honasa Consumer Acquires 58% Stake in Fluence Pharma for Nutraceuticals Entry

Honasa Consumer Limited has acquired a 58% majority stake in Fluence Pharma, a science-backed nutraceuticals company, marking its strategic entry into the high-growth nutraceuticals market. This move aims to leverage Fluence Pharma's patented Cyclical Nutrition Therapy (CNT) and dermatologist network to build a B2C nutrition portfolio under a new subsidiary, Honasa Health Private Limited. Fluence Pharma reported approximately ₹40 Crore revenue and over 20% EBITDA margin in FY26. The acquisition aligns with Honasa's vision of offering holistic, 'inside-out' beauty solutions and diversifying its growth engine.